223 related articles for article (PubMed ID: 38410099)
1. Cardiovascular disease and lung cancer.
de Jesus M; Chanda A; Grabauskas T; Kumar M; Kim AS
Front Oncol; 2024; 14():1258991. PubMed ID: 38410099
[TBL] [Abstract][Full Text] [Related]
2. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer.
Sun JY; Zhang ZY; Qu Q; Wang N; Zhang YM; Miao LF; Wang J; Wu LD; Liu Y; Zhang CY; Wang RX
Int J Cardiol; 2021 May; 330():186-193. PubMed ID: 33581175
[TBL] [Abstract][Full Text] [Related]
4. Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review.
Chan SHY; Khatib Y; Webley S; Layton D; Salek S
Front Pharmacol; 2023; 14():1137983. PubMed ID: 37383708
[No Abstract] [Full Text] [Related]
5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
6. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease.
Whelton SP; Berning P; Blumenthal RS; Marshall CH; Martin SS; Mortensen MB; Blaha MJ; Dzaye O
Eur J Intern Med; 2021 May; 87():3-12. PubMed ID: 33610416
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary embolism and bradycardia in a NSCLC patient treated with crizotinib for a rare mutation.
Shi Y; Qiu Z; Ding Y; Chen Y; Zhang A; Jin W
J Oncol Pharm Pract; 2023 Jan; 29(1):211-217. PubMed ID: 35466809
[TBL] [Abstract][Full Text] [Related]
9. Amplifying Outcomes: Checkpoint Inhibitor Combinations in First-Line Non-Small Cell Lung Cancer.
Melosky B; Juergens R; Hirsh V; McLeod D; Leighl N; Tsao MS; Card PB; Chu Q
Oncologist; 2020 Jan; 25(1):64-77. PubMed ID: 31138727
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?
Sun F; Franks K; Murray L; Lilley J; Wheller B; Banfill K; McWilliam A; Abravan A; Van Herk M; Faivre-Finn C; Cubbon R
Lung Cancer; 2020 Aug; 146():1-5. PubMed ID: 32460218
[TBL] [Abstract][Full Text] [Related]
11. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L; Liu Y; Wang Y
Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
[TBL] [Abstract][Full Text] [Related]
12. The landscape of immune checkpoint inhibitor therapy in advanced lung cancer.
Wang C; Li J; Zhang Q; Wu J; Xiao Y; Song L; Gong H; Li Y
BMC Cancer; 2021 Aug; 21(1):968. PubMed ID: 34454455
[TBL] [Abstract][Full Text] [Related]
13. Dual effect of radiotherapy related concomitant cardiovascular diseases in non-small cell lung cancer.
Mo Y; Tian B; Wu M; Chen M; Chen D; Yu J
Cancer Med; 2023 Jan; 12(2):1025-1034. PubMed ID: 35754191
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.
Sase K; Fujisaka Y; Shoji M; Mukai M
Curr Treat Options Oncol; 2021 Jun; 22(8):71. PubMed ID: 34110522
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment of lung cancer in older patients: A review.
Radovic M; Kanesvaran R; Rittmeyer A; Früh M; Minervini F; Glatzer M; Putora PM
J Geriatr Oncol; 2019 May; 10(3):405-410. PubMed ID: 30292418
[TBL] [Abstract][Full Text] [Related]
16. Cancer and cardiovascular disease: can understanding the mechanisms of cardiovascular injury guide us to optimise care in cancer survivors?
Truong LL; Scott L; Pal RS; Jalink M; Gunasekara S; Wijeratne DT
Ecancermedicalscience; 2022; 16():1430. PubMed ID: 36158986
[TBL] [Abstract][Full Text] [Related]
17. Adverse Event Management in Patients with
Chalmers A; Cannon L; Akerley W
Oncologist; 2019 Jul; 24(7):963-972. PubMed ID: 30598499
[TBL] [Abstract][Full Text] [Related]
18. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
